Metraipolis › archive › dc_5cf1b0ced185

Interleukin-6-to-lymphocyte ratio as a novel prognostic factor in patients with severe fever with thrombocytopenia syndrome: a discovery and validation study — Europe PMC PMID:41958665

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41958665
DOI
10.3389/fimmu.2026.1780148
License (as archived)
solo-consultazione
Archived
2026-11-03T23:04:44.255Z
SHA-256 of the archived text
c966e849a837115849df0c7a69e2b586eb47a12de9c00f6c72a7a0ed6220e0fa
Stable URL of this page
https://metraipolis.com/documento/dc_5cf1b0ced185

How to cite

Interleukin-6-to-lymphocyte ratio as a novel prognostic factor in patients with severe fever with thrombocytopenia syndrome: a discovery and validation study — Europe PMC PMID:41958665 — Europe PMC (en), https://europepmc.org/article/MED/41958665 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5cf1b0ced185 (Metraipolis archive dc_5cf1b0ced185, sha256 c966e849a837115849df0c7a69e2b586eb47a12de9c00f6c72a7a0ed6220e0fa)
BibTeX
@misc{dc5cf1b0ced185,
  title = {Interleukin-6-to-lymphocyte ratio as a novel prognostic factor in patients with severe fever with thrombocytopenia syndrome: a discovery and validation study — Europe PMC PMID:41958665},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41958665},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5cf1b0ced185; sha256 c966e849a837115849df0c7a69e2b586eb47a12de9c00f6c72a7a0ed6220e0fa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41958665. Agents can read the archived copy with the MCP tool read_document.